SCHEMBL30207994

SCHEMBL30207994

Cc1ncnc2c1ccn2[C@@H]1C[C@H](C(O)c2ccc(Cl)cc2CN)[C@H]2OC(C)(C)O[C@H]21

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 0.45
▸ WDR77 Q9BQA1 19/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19667408 1.00 PRMT5 (0.45) PRMT5WDR77
SCHEMBL30208000 1.00 PRMT5 (0.45) PRMT5WDR77
SCHEMBL19667289 0.86 PRMT5 (0.42) PRMT5WDR77
SCHEMBL20488475 0.86 PRMT5 (0.52) PRMT5WDR77
SCHEMBL20488476 0.86 PRMT5 (0.52) PRMT5WDR77
SCHEMBL20488478 0.85 PRMT5 (0.43) PRMT5WDR77
SCHEMBL21359308 0.85 PRMT5 (0.43) PRMT5WDR77
SCHEMBL20488479 0.85 PRMT5 (0.43) PRMT5WDR77
SCHEMBL29383366 0.85 PRMT5 (0.43) PRMT5WDR77
SCHEMBL19679383 0.85 PRMT5 (0.55) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709389-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 Celgene Corporation (US) 2026-03-18 — — EP disclosed
WO-2024233747-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 CELGENE CORPORATION (US) 2024-11-14 — — WO disclosed
CN-109890797-B Substituted carbon nucleoside derivatives useful as anticancer agents 辉瑞公司 2023-02-28 — — CN disclosed
Send feedback